867000 | KRN7000
α-Galactosyl Ceramide

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
KRN7000
α-Galactosyl Ceramide
CAS Registry Number is a Registered Trademark of the American Chemical Society
(2S,3S,4R)-1-O-(D-galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol
Zhu Y, Smith DJ, Zhou Y, Li YR, Yu J, Lee D, Wang YC, Di Biase S, Wang X, Hardoy C, Ku J, Tsao T, Lin LJ, Pham AT, Moon H, McLaughlin J, Cheng D, Hollis RP, Campo-Fernandez B, Urbinati F, Wei L, Pang L, Rezek V, Berent-Maoz B, Macabali MH, Gjertson D, Wang X, Galic Z, Kitchen SG, An DS, Hu-Lieskovan S, Kaplan-Lefko PJ, De Oliveira SN, Seet CS, Larson SM, Forman SJ, Heath JR, Zack JA, Crooks GM, Radu CG, Ribas A, Kohn DB, Witte ON, Yang L. Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer. Cell Stem Cell. 2019 Oct 3;25(4):542-557.e9. doi: 10.1016/j.stem.2019.08.004. Epub 2019 Sep 5.
PubMed ID: 31495780Guevara ML, Jilesen Z, Stojdl D, Persano S. Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration. ACS Omega. 2019 Aug 7;4(8):13015-13026. doi: 10.1021/acsomega.9b00489. eCollection 2019 Aug 20.
PubMed ID: 31460428Pereira CS, Pérez-Cabezas B, Ribeiro H, Maia ML, Cardoso MT, Dias AF, Azevedo O, Ferreira MF, Garcia P, Rodrigues E, Castro-Chaves P, Martins E, Aguiar P, Pineda M, Amraoui Y, Fecarotta S, Leão-Teles E, Deng S, Savage PB, Macedo MF. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients. Front Immunol. 2019 Jun 4;10:1264. doi: 10.3389/fimmu.2019.01264. eCollection 2019.
PubMed ID: 31214199Yu KKQ, Wilburn DB, Hackney JA, Darrah PA, Foulds KE, James CA, Smith MT, Jing L, Seder RA, Roederer M, Koelle DM, Swanson WJ, Seshadri C. Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates. Immunogenetics. 2019 May 23. doi: 10.1007/s00251-019-01118-9. [Epub ahead of print]
PubMed ID: 31123763Lu Y, Zhong MC, Qian J, Calderon V, Cruz Tleugabulova M, Mallevaey T, Veillette A. SLAM receptors foster iNKT cell development by reducing TCR signal strength after positive selection. Nat Immunol. 2019 Apr;20(4):447-457. doi: 10.1038/s41590-019-0334-0. Epub 2019 Mar 4.
PubMed ID: 30833791Fuji N, Ueda Y, Fujiwara H, Toh T, Yoshimura T, Yamagishi H. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Clin Cancer Res. 2000 Aug;6(8):3380-7.
PubMed ID: 10955826- Certificate of Analysis (Lot No. 867000P-1MG-A-013 and 6153PGA013)
- Certificate of Analysis (Lot No. 867000P-1MG-A-014 and 6153PGA014)
- Certificate of Analysis (Lot No. 867000P-1MG-B-014 and 6153PGB014)
- Certificate of Analysis (Lot No. 867000P-1MG-C-014 and 6153PGC014)
- Certificate of Analysis (Lot No. 867000P-1MG-A-015 and 6153PGA015)
- Certificate of Analysis (Lot No. 867000P-1MG-B-015 and 6153PGB015)
- Certificate of Analysis (Lot No. 867000P-1MG-A-016 and 6153PGA016)
- Certificate of Analysis (Lot No. 867000P-1MG-D-015 and 6153PGD015)
- Certificate of Analysis (Lot No. 867000P-1MG-E-015 and 6153PGE015)
- Certificate of Analysis (Lot No. 867000P-1MG-F-015 and 6153PGF015)
- Certificate of Analysis (Lot No. 867000P-1MG-G-015 and 6153PGG015)
- Certificate of Analysis (Lot No. 867000P-1MG-I-015 and 6153PGI015)
- Certificate of Analysis (Lot No. 867000P-1MG-B-016 and 6153PGB016)